We study DNA repair by homologous recombination in mitotic and meiotic contexts, and seek to identify new factors that may influence this mechanism.
Genomes are dynamic structures, evolving not only through point mutations, but also through Gross Chromosomal Rearrangements (GCRs). At population level, these dynamics contribute to the evolution of the species, but at individual level, they are responsible for numerous diseases, including cancer. RGCs include chromosome arm translocations, as well as variations in the copy number of large chromosome segments. RGCs and point mutations are formed in part during the repair of DNA breaks by recombination between homologous sequences during mitosis and meiosis.
DNA recombination between homologous sequences is a repair mechanism for various DNA lesions, including double-strand breaks. We are studying this mechanism in detail in both mitotic and meiotic contexts, and are seeking to identify new factors that may influence it. To this end, we are combining molecular genetic and genomic approaches using budding yeasts such as the baker's yeast Saccharomyces cerevisiae and related species, as well as the mouse model.
The projects
Our first line of research focuses on the regulation of recombination events involving a single DNA end. These events are known to generate chromosomal rearrangements (GCRs) and are particularly mutagenic.
Although these events are generally repressed, they can occur as a last resort to repair damaged DNA. They also play a key role in maintaining chromosome ends, known as telomeres, in a significant fraction of ALT cancers.
Our second line of research focuses on the regulation of recombination during meiosis, the cell division that generates gametes and is essential for sexual reproduction.
Meiotic recombination is part of a rigorously controlled cellular program. It plays a key role in the correct segregation of chromosomes and contributes to genetic mixing. Having studied in detail the dynamics of exchanges between DNA molecules during meiotic recombination, we now turn our attention to the impact of DNA polymorphism on the efficiency of this process.
DNA polymorphism, naturally present in populations, generates base mismatches during recombination. These mismatches are detected by a protein machinery that can either repair them or eliminate the recombination intermediates. This mechanism ensures efficient allelic recombination while preventing recombination between homologous non-allelic sequences, potential sources of chromosomal rearrangements (GCRs).
A third line of research focuses on the study of meiotic recombination in budding yeasts related to Saccharomyces cerevisiae.
We are particularly interested in an as-yet-unknown mechanism that inhibits meiotic recombination on the entire arm of the chromosome carrying the sex-type locus in the yeast Lachancea kluyveri.
This mechanism could shed new light on a pathway for the emergence of **sex chromosomes**, which are often characterized by a massive extinction of meiotic recombination.
The laboratory's fourth theme is the regulation of recombination between sex chromosomes during male meiosis in the mouse. Unlike autosome pairs, the challenge for the X and Y chromosomes in male mammals is to recombine in their region of very limited homology, called pseudoautosomal region (PAR), to ensure their correct segregation at meiosis I.
To ensure this recombination, the mo-2 minisatellite present in the PAR and thehyperaccumulation of pro-recombination factors establish respectively a cis- and trans-regulation.
We aim to further characterize the proteome associated with PAR, to refine the characterization of its particular chromatin structure and to study its evolution since its associated minisatellite mo-2 probably favors rapid evolution.
Team news
featured publications
03/2024
Legrand S, Saifudeen A, Bordelet H, Vernerey J, Guille A, Bignaud A, Thierry A, Acquaviva L, Gaudin M, Sanchez A, Johnson D, Friedrich A, Schacherer J, Neale MJ, Borde V, Koszul R, Llorente B.
06/2022
Uribe-Calvillo T, Maestroni L, Marsolier MC, Khadaroo B, Arbiol C, Schott J, Llorente B.
04/2018
Marsolier-Kergoat MC, Khan MM, Schott J, Zhu X, Llorente B.
09/2012
Costelloe T, Louge R, Tomimatsu N, Mukherjee B, Martini E, Khadaroo B, Dubois K, Wiegant WW, Thierry A, Burma S, van Attikum H, Llorente B.
09/2011
Martini E, Borde V, Legendre M, Audic S, Regnault B, Soubigou G, Dujon B, Llorente B.
05/2007
Smith CE, Llorente B, Symington LS.


Like others, they were part of the team. Thank you to all those who have contributed to CRCM's excellence and impact.



